Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments [PDF]
Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2019 Objective Large demyelinating lesions with possible mass effect (tumefactive multiple sclerosis or tumefactive demyelination) can be mistaken for tumour-like space-occupying lesions suggesting a malignant outcome.
Staley A Brod +2 more
doaj +3 more sources
Paraneoplastic Tumefactive Demyelination With Underlying Anaplastic Thyroid Cancer: A Case Report and Review of the Literature [PDF]
Journal of Central Nervous System DiseaseWe present a case of paraneoplastic tumefactive demyelination in a 55-year-old female with an underlying anaplastic thyroid carcinoma (ATC), alongside a review of the literature on all cases of tumefactive demyelination associated with non-CNS neoplasia.
Chaloulos-Iakovidis Panagiotis +9 more
doaj +3 more sources
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm [PDF]
Journal of Clinical and Diagnostic Research, 2016 Demyelinating disease presenting with clinical and radiologic features similar to a brain tumour is referred to as tumefactive demyelination. These lesions pose considerable diagnostic uncertainty.
Tom George +3 more
doaj +4 more sources
Isolated medullary tumefactive demyelination masquerading as tumor [PDF]
Annals of Indian Academy of Neurology, 2022 +5 more
doaj +4 more sources
Case Report: Paraneoplastic Tumefactive Demyelination Associated With Seminoma [PDF]
Frontiers in Neurology, 2022 Paraneoplastic tumefactive demyelination (TD) is a rare disorder of the central nervous system that can be challenging to diagnose. Here, we describe a 32-year-old Japanese man with a TD associated with testicular seminoma.
Wataru Shiraishi +7 more
doaj +2 more sources
Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A [PDF]
Radiology Case Reports, 2022 The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology.
Victor Oliveira Araújo +12 more
doaj +2 more sources
When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis [PDF]
CNS Oncology, 2021 Oligodendrogliomas are slow-growing tumors that account for 15–20% of gliomas. This case report describes the case of an adult male patient diagnosed initially with tumefactive demyelination and multiple sclerosis, which was subsequently found to be a ...
Breanna Taylor +2 more
doaj +2 more sources
A rare case of tumefactive demyelination of brain: A case report and literature review [PDF]
Clinical Case Reports, 2023 This case report highlights the diagnostic challenges encountered in a 30‐year‐old female presenting with fever followed by Wernicke's aphasia without right‐sided weakness, ultimately diagnosed as tumefactive demyelination (TD). TD is a rare neurological
Pugazhendi Inban +6 more
doaj +2 more sources
A case of relapsing-remitting tumefactive demyelination
Annals of Indian Academy of Neurology, 2019 Ankur Wadhwa +4 more
doaj +4 more sources
Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients [PDF]
Annals of Clinical and Translational Neurology, 2023 Objective To describe demographic, clinical, and radiographic features of tumefactive demyelination (TD) and identify factors associated with severe attacks and poor outcomes.
Mahboubeh Fereidan‐Esfahani +8 more
doaj +2 more sources